Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

1.16
0.0000
Post-market: 1.170.0100+0.86%19:21 EDT
Volume:84.35K
Turnover:96.95K
Market Cap:4.50M
PE:-0.12
High:1.17
Open:1.17
Low:1.12
Close:1.16
52wk High:24.30
52wk Low:1.03
Shares:3.88M
Float Shares:3.81M
Volume Ratio:0.35
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.16
PE(LYR):-0.08

Loading ...

Apr 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 21, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Major Issues Report

8-K - Current report
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 10, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 08, 2022

Major Issues Report

8-K - Current report
Feb 03, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 24, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals